Systems and Methods for Producing Carbon Solids
US-2024417566-A1 · Dec 19, 2024 · US
US10224398B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10224398-B2 |
| Application number | US-201113976621-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 23, 2011 |
| Priority date | Dec 28, 2010 |
| Publication date | Mar 5, 2019 |
| Grant date | Mar 5, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Semiconductor nanocrystals prepared using a mixture of organic ligands (e.g., oxoacids), as well as compositions, kits, and methods of using such semiconductor nanocrystals are disclosed.
Opening claim text (preview).
What is claimed is: 1. A population of semiconductor nanocrystals, wherein each nanocrystal in the population comprises: a) an elongated semiconductor core comprising CdSe or CdSeTe; and b) a semiconductor shell layer disposed on the semiconductor core, and at least two different oxoacid compounds, wherein the at least two different oxoacid compounds comprise ethylphosphonic acid and tetradecylphosphonic acid, wherein the mole fraction of ethylphosphonic acid relative to the total number of moles of oxoacid compounds is greater than about 0.5%, wherein the population of semiconductor nanocrystals exhibits a quantum yield of greater than 70%, wherein the semiconductor core of each nanocrystal has a first aspect ratio and the nanocrystal has a second aspect ratio, wherein the second aspect ratio is less than the first aspect ratio. 2. The population of claim 1 , wherein each nanocrystal in the population further comprises a hydrophilic overcoating on the semiconductor shell layer that renders the nanocrystal dispersible in an aqueous medium. 3. The population of claim 1 , wherein each nanocrystal in the population is associated with a biological molecule, cell, or drug. 4. The population of claim 1 , wherein the shell layer comprises a semiconductor material selected from the group consisting of a Group II-VI, Group II-VI-VI, Group III-V, Group III-III-V, Group III-V-V and Group II-II-VI semiconductor material. 5. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is greater than about 2%. 6. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is greater than about 5%. 7. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is about 0.5% to about 20%. 8. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is about 2% to about 20%. 9. The population of claim 1 , wherein the mole fraction of the ethylphosphonic acid relative to the total number of moles of oxoacid compounds is about 5% to about 15%. 10. A dispersion of semiconductor nanocrystals, comprising: a population of semiconductor nanocrystals according to claim 1 ; and an aqueous or organic medium. 11. A kit for labeling cells, comprising a) a population of semiconductor nanocrystals according to claim 1 ; and b) instructions for labeling cells with the population of nanocrystals. 12. A method of detecting a target species in a sample, comprising: contacting a sample suspected of containing a target species with the population of claim 1 for a time sufficient to bind the target species to at least one nanocrystal in the population; and monitoring fluorescence emission to detect the presence of the at least one nanocrystal, thereby detecting the target species in the sample. 13. A population of semiconductor nanocrystals, wherein each nanocrystal in the population comprises: a) an elongated semiconductor core; and b) a semiconductor shell layer disposed on the semiconductor core, and at least two different oxoacid compounds, wherein the at least two different oxoacid compounds comprise ethylphosphonic acid and tetradecylphosphonic acid, wherein the semiconductor core of each nanocrystal has a first aspect ratio and the nanocrystal has a second aspect ratio, wherein the second aspect ratio is less than the first aspect ratio. 14. The population of semiconductor nanocrystals of claim 13 , wherein the elongated semiconductor core comprises CdSe or CdSeTe. 15. The population of semiconductor nanocrystals of claim 13 , wherein the population of semiconductor nanocrystals exhibits a quantum yield of greater than 70%. 16. A population of semiconductor nanocrystals, wherein each nanocrystal in the population comprises: a) an elongated semiconductor core comprising CdSe or CdSeTe; and b) a semiconductor shell layer disposed on the semiconductor core, and at least two different oxoacid compounds, wherein the at least two different oxoacid compounds comprise a first oxoacid compound with a lower molecular weight and a second oxoacid compound with a higher molecular weight, wherein the mole fraction of the lower molecular weight oxoacid compound relative to the total number of moles of oxoacid compounds is greater than about 0.5%, wherein the first oxoacid compound is selected from C 1 -C 10 alkylphosphonic acid compounds and the second oxoacid compound is selected from C 10 -C 20 alkylphosphonic acid compounds, wherein the population of semiconductor nanocrystals exhibits a quantum yield of greater than 70%, wherein the semiconductor core of each nanocrystal has a first aspect ratio and the nanocrystal has a second aspect ratio, wherein the second aspect ratio is less than the first aspect ratio. 17. The population of claim 16 , wherein at least one of the oxoacid compounds is methylphosphonic acid, butylphosphonic acid, hexylphosphonic acid or octylphosphonic acid.
using solutions · CPC title
AIIIBV compounds {wherein A is B, Al, Ga, In or Tl and B is N, P, As, Sb or Bi} · CPC title
characterised by shape · CPC title
Nanooptics, e.g. quantum optics or photonic crystals · CPC title
Manufacture or treatment of nanostructures · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.